Fine Beautiful Aurobindo Pharma Financial Statements
2 MAITRI VIHAR AMEERPET HYDERABAD - 500 038 TELANGANA INDIA CORPORATE OFFICE.
Aurobindo pharma financial statements. Analyse Income statement Cashflow statement and balance sheet of Aurobindo Pharma. 3728176 crore on 15 June 2015. Six prime therapeutic areas of medication addressed by the company are anti-allergic gastroenterology antiretroviral antibiotics central nervous system and cardiology.
Cash Flow Statement 110 Consolidated Financial Statements 143. Get Aurobindo Pharma latest Profit Loss account Financial Statements and Aurobindo Pharma detailed profit and loss accounts. By Financial Statement Analysis of Aurobindo Pharma we were able to get a fair picture of the financial position of Aurobindo Pharma.
NSE Gainer-Large Cap. The income statement indicates a companys financial performance measured over a. Get Aurobindo Pharma latest Key Financial Ratios Financial Statements and Aurobindo Pharma detailed profit and loss accounts.
Aurobindo Pharma Valuation Step 2. Revenue Growth Rates. The assumptions used for forecasting are tabulated below.
Forecasting the Financial Statements. The financial statements are forecasted for a period of 5 years using the annual report data of the company. Jubilant Food 359000 16005.
Get Aurobindo Pharma latest Consolidated Half Yearly Results Financial Statements and State Aurobindo Pharma detailed profit and loss accounts. Antibiotics anti-retrovirals cardiovascular products central nervous system products gastroenterologicals and. Find out the revenue expenses and profit or loss over the last fiscal year.